UPDATE – Friday, March 27, 2026
OTTAWA, ON, March 27, 2026 Note: All times local Halifax, Nova Scotia 9:00 a.m. The Prime Minister will deliver remarks and participate in a featured conversation... Read more.
Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
Data from 1,868 Surveillance, Epidemiology and End Results (SEER)-linked patients show DecisionDx-Melanoma significantly stratifies five-year melanoma-specific survival... Read more.
REBEL Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
The tech-driven marketplace tackles retail’s excess inventory problem and makes top brands accessible at a fraction of retail price KANNAPOLIS, N.C., March... Read more.
United By Nature Launches New Cultural Movement to Unite Americans Around the Outdoors
Going Public invites Americans to claim a symbolic share of the public lands they already own NEW YORK, March 27, 2026 /PRNewswire/ — Today, United By Nature,... Read more.
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
GALWAY, Ireland, March 27, 2026 /PRNewswire/ — Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration... Read more.
It All Started with a Chinese Candy Wrapper: A Sweet Story in Milan
BEIJING, March 27, 2026 /PRNewswire/ — A news report from China.org.cn on a story sparked by a Chinese Candy Wrapper in Milan: Karem, a front desk clerk... Read more.
UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa
Symptom control throughout three years: 86.1% of people living with moderate-to-severe hidradenitis suppurativa (HS) treated with BIMZELX had no acute exacerbation... Read more.
UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
Post hoc analyses of BIMZELX (bimekizumab-bkzx) using the first consensus definition of psoriasis on-treatment remission: Published by the National Psoriasis Foundation... Read more.
DEEPX Secures 27 Commercial Orders Across 8 Countries Within 7 Months of Mass Production
Global adoption of Physical AI chips accelerates as industry demand expands across robotics, smart factories, and edge AI — backed by a growing partner ecosystem... Read more.
BSI Standards Join ASTM Compass® Platform
The partnership signifies one of the platform’s largest-ever content additions. W. CONSHOHOCKEN, Pa., March 27, 2026 /PRNewswire/ — The British Standards... Read more.